255 related articles for article (PubMed ID: 22892715)
1. Schizophrenia shows a unique metabolomics signature in plasma.
He Y; Yu Z; Giegling I; Xie L; Hartmann AM; Prehn C; Adamski J; Kahn R; Li Y; Illig T; Wang-Sattler R; Rujescu D
Transl Psychiatry; 2012 Aug; 2(8):e149. PubMed ID: 22892715
[TBL] [Abstract][Full Text] [Related]
2. Alteration of lipids and amino acids in plasma distinguish schizophrenia patients from controls: A targeted metabolomics study.
Liu Y; Song X; Liu X; Pu J; Gui S; Xu S; Tian L; Zhong X; Zhao L; Wang H; Liu L; Xu G; Xie P
Psychiatry Clin Neurosci; 2021 Apr; 75(4):138-144. PubMed ID: 33421228
[TBL] [Abstract][Full Text] [Related]
3. Targeted metabolomics-based understanding of the sleep disturbances in drug-naïve patients with schizophrenia.
Yan H; Li G; Zhang X; Zhang C; Li M; Qiu Y; Sun W; Dong Y; Li S; Li J
BMC Psychiatry; 2024 May; 24(1):355. PubMed ID: 38741058
[TBL] [Abstract][Full Text] [Related]
4. Metabolomics in serum of patients with non-advanced age-related macular degeneration reveals aberrations in the glutamine pathway.
Kersten E; Dammeier S; Ajana S; Groenewoud JMM; Codrea M; Klose F; Lechanteur YT; Fauser S; Ueffing M; Delcourt C; Hoyng CB; de Jong EK; den Hollander AI;
PLoS One; 2019; 14(6):e0218457. PubMed ID: 31220133
[TBL] [Abstract][Full Text] [Related]
5. Serum amino acid metabolic profiles of ankylosing spondylitis by targeted metabolomics analysis.
Zhou Y; Zhang X; Chen R; Han S; Liu Y; Liu X; Gao M; Yang C; Lu D; Sun B; Chen H
Clin Rheumatol; 2020 Aug; 39(8):2325-2336. PubMed ID: 32130577
[TBL] [Abstract][Full Text] [Related]
6. Metabolomics approach revealed robust changes in amino acid and biogenic amine signatures in patients with schizophrenia in the early course of the disease.
Parksepp M; Leppik L; Koch K; Uppin K; Kangro R; Haring L; Vasar E; Zilmer M
Sci Rep; 2020 Aug; 10(1):13983. PubMed ID: 32814830
[TBL] [Abstract][Full Text] [Related]
7. High-resolution metabolomic profiling of Alzheimer's disease in plasma.
Niedzwiecki MM; Walker DI; Howell JC; Watts KD; Jones DP; Miller GW; Hu WT
Ann Clin Transl Neurol; 2020 Jan; 7(1):36-45. PubMed ID: 31828981
[TBL] [Abstract][Full Text] [Related]
8. Association of a Reproducible Epigenetic Risk Profile for Schizophrenia With Brain Methylation and Function.
Chen J; Zang Z; Braun U; Schwarz K; Harneit A; Kremer T; Ma R; Schweiger J; Moessnang C; Geiger L; Cao H; Degenhardt F; Nöthen MM; Tost H; Meyer-Lindenberg A; Schwarz E
JAMA Psychiatry; 2020 Jun; 77(6):628-636. PubMed ID: 32049268
[TBL] [Abstract][Full Text] [Related]
9. Gene expression in the peripheral leukocytes and association analysis of PDLIM5 gene in schizophrenia.
Numata S; Ueno S; Iga J; Yamauchi K; Hongwei S; Hashimoto R; Takeda M; Kunugi H; Itakura M; Ohmori T
Neurosci Lett; 2007 Mar; 415(1):28-33. PubMed ID: 17287082
[TBL] [Abstract][Full Text] [Related]
10. An Untargeted Metabolomics Analysis of Antipsychotic Use in Bipolar Disorder.
Burghardt KJ; Evans SJ; Wiese KM; Ellingrod VL
Clin Transl Sci; 2015 Oct; 8(5):432-40. PubMed ID: 26314700
[TBL] [Abstract][Full Text] [Related]
11. Serum metabolic profiling using small molecular water-soluble metabolites in individuals with schizophrenia: A longitudinal study using a pre-post-treatment design.
Cao B; Jin M; Brietzke E; McIntyre RS; Wang D; Rosenblat JD; Ragguett RM; Zhang C; Sun X; Rong C; Wang J
Psychiatry Clin Neurosci; 2019 Mar; 73(3):100-108. PubMed ID: 30156046
[TBL] [Abstract][Full Text] [Related]
12. Metabolic profiling in children with autism spectrum disorder with and without mental regression: preliminary results from a cross-sectional case-control study.
Rangel-Huerta OD; Gomez-Fernández A; de la Torre-Aguilar MJ; Gil A; Perez-Navero JL; Flores-Rojas K; Martín-Borreguero P; Gil-Campos M
Metabolomics; 2019 Jun; 15(7):99. PubMed ID: 31250215
[TBL] [Abstract][Full Text] [Related]
13. Serum Metabolic Profiles of Chinese Women With Perimenopausal Obesity Explored by the Untargeted Metabolomics Approach.
Ding S; Chen M; Liao Y; Chen Q; Lin X; Chen S; Chai Y; Li C; Asakawa T
Front Endocrinol (Lausanne); 2021; 12():637317. PubMed ID: 34630316
[TBL] [Abstract][Full Text] [Related]
14. Reconstruction and analysis of correlation networks based on GC-MS metabolomics data for hypercholesterolemia.
OuYang YN; Zhou LX; Jin YX; Hou GF; Yang PF; Chen M; Tian Z
Biochem Biophys Res Commun; 2021 May; 553():1-8. PubMed ID: 33752091
[TBL] [Abstract][Full Text] [Related]
15. Explore potential plasma biomarkers of acute respiratory distress syndrome (ARDS) using GC-MS metabolomics analysis.
Lin S; Yue X; Wu H; Han TL; Zhu J; Wang C; Lei M; Zhang M; Liu Q; Xu F
Clin Biochem; 2019 Apr; 66():49-56. PubMed ID: 30779905
[TBL] [Abstract][Full Text] [Related]
16. Discovery and Validation of Potential Serum Biomarkers for Pediatric Patients with Congenital Heart Diseases by Metabolomics.
Yu M; Sun S; Yu J; Du F; Zhang S; Yang W; Xiao J; Xie B
J Proteome Res; 2018 Oct; 17(10):3517-3525. PubMed ID: 30207476
[TBL] [Abstract][Full Text] [Related]
17. GC-MS based metabolomics identification of possible novel biomarkers for schizophrenia in peripheral blood mononuclear cells.
Liu ML; Zheng P; Liu Z; Xu Y; Mu J; Guo J; Huang T; Meng HQ; Xie P
Mol Biosyst; 2014 Jul; 10(9):2398-406. PubMed ID: 24975926
[TBL] [Abstract][Full Text] [Related]
18. Asymmetric dimethylarginine in somatically healthy schizophrenia patients treated with atypical antipsychotics: a case-control study.
Jorgensen A; Knorr U; Soendergaard MG; Lykkesfeldt J; Fink-Jensen A; Poulsen HE; Jorgensen MB; Olsen NV; Staalsø JM
BMC Psychiatry; 2015 Apr; 15():67. PubMed ID: 25880260
[TBL] [Abstract][Full Text] [Related]
19. Altered metabolic profiles and biomarkers associated with astragaloside IV-mediated protection against cisplatin-induced acute kidney injury in rats: An HPLC-TOF/MS-based untargeted metabolomics study.
Song Y; Hu T; Gao H; Zhai J; Gong J; Zhang Y; Tao L; Sun J; Li Z; Qu X
Biochem Pharmacol; 2021 Jan; 183():114299. PubMed ID: 33148504
[TBL] [Abstract][Full Text] [Related]
20. Metabolomic analysis of biochemical changes in the plasma and urine of first-episode neuroleptic-naïve schizophrenia patients after treatment with risperidone.
Cai HL; Li HD; Yan XZ; Sun B; Zhang Q; Yan M; Zhang WY; Jiang P; Zhu RH; Liu YP; Fang PF; Xu P; Yuan HY; Zhang XH; Hu L; Yang W; Ye HS
J Proteome Res; 2012 Aug; 11(8):4338-50. PubMed ID: 22800120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
